Cantharidin alters the expression of genes associated with the NKG2D-associated immune response in TSGH-8301 human bladder carcinoma cells. 2017

Jehn-Hwa Kuo, and An-Cheng Huang, and Jen-Jyh Lin, and Kuang-Chi Lai, and Rick Sai-Chuen Wu, and Jiun-Long Yang, and Bin-Chuan Ji, and Mei-Due Yang, and Yung-Lin Chu, and Jing-Gung Chung
Special Class of Healthcare, Industry Management, Central Taiwan University of Science and Technology, Taichung 40601, Taiwan, R.O.C.

Cantharidin (CTD) is a natural toxin in beetles of the Mylabris genus (blister beetle), which has been revealed to induce cell death in various types of human cancer cells. However, to the best of our knowledge, no previous studies have investigated the effect of CTD on the expression of genes and their associated signaling pathways in human bladder carcinoma cells. In the present study, CTD-induced cell morphological changes and apoptosis were observed using phase-contrast microscopy and the terminal deoxynucleotidyl transferase dUTP nick end labeling assay, respectively, in TSGH-8301 human bladder carcinoma cells. In addition, a complementary DNA microarray analysis demonstrated that CTD treatment led to a >2-fold upregulation of 269 genes. For example, the DNA damage-associated gene DNA-damage-inducible transcript 3 had a 4.75-fold upregulation. Furthermore, another 286 genes were >2-fold downregulated in response to CTD treatment. Matrix-remodeling associated 5, which is associated with cell migration and invasion, was downregulated 7.98-fold.

UI MeSH Term Description Entries

Related Publications

Jehn-Hwa Kuo, and An-Cheng Huang, and Jen-Jyh Lin, and Kuang-Chi Lai, and Rick Sai-Chuen Wu, and Jiun-Long Yang, and Bin-Chuan Ji, and Mei-Due Yang, and Yung-Lin Chu, and Jing-Gung Chung
November 2010, International journal of oncology,
Jehn-Hwa Kuo, and An-Cheng Huang, and Jen-Jyh Lin, and Kuang-Chi Lai, and Rick Sai-Chuen Wu, and Jiun-Long Yang, and Bin-Chuan Ji, and Mei-Due Yang, and Yung-Lin Chu, and Jing-Gung Chung
March 1988, Journal of surgical oncology,
Jehn-Hwa Kuo, and An-Cheng Huang, and Jen-Jyh Lin, and Kuang-Chi Lai, and Rick Sai-Chuen Wu, and Jiun-Long Yang, and Bin-Chuan Ji, and Mei-Due Yang, and Yung-Lin Chu, and Jing-Gung Chung
April 1988, Proceedings of the National Science Council, Republic of China. Part B, Life sciences,
Jehn-Hwa Kuo, and An-Cheng Huang, and Jen-Jyh Lin, and Kuang-Chi Lai, and Rick Sai-Chuen Wu, and Jiun-Long Yang, and Bin-Chuan Ji, and Mei-Due Yang, and Yung-Lin Chu, and Jing-Gung Chung
January 2000, Anticancer research,
Jehn-Hwa Kuo, and An-Cheng Huang, and Jen-Jyh Lin, and Kuang-Chi Lai, and Rick Sai-Chuen Wu, and Jiun-Long Yang, and Bin-Chuan Ji, and Mei-Due Yang, and Yung-Lin Chu, and Jing-Gung Chung
April 2019, Anticancer research,
Jehn-Hwa Kuo, and An-Cheng Huang, and Jen-Jyh Lin, and Kuang-Chi Lai, and Rick Sai-Chuen Wu, and Jiun-Long Yang, and Bin-Chuan Ji, and Mei-Due Yang, and Yung-Lin Chu, and Jing-Gung Chung
June 2003, Pharmacology & toxicology,
Jehn-Hwa Kuo, and An-Cheng Huang, and Jen-Jyh Lin, and Kuang-Chi Lai, and Rick Sai-Chuen Wu, and Jiun-Long Yang, and Bin-Chuan Ji, and Mei-Due Yang, and Yung-Lin Chu, and Jing-Gung Chung
September 2012, International journal of oncology,
Jehn-Hwa Kuo, and An-Cheng Huang, and Jen-Jyh Lin, and Kuang-Chi Lai, and Rick Sai-Chuen Wu, and Jiun-Long Yang, and Bin-Chuan Ji, and Mei-Due Yang, and Yung-Lin Chu, and Jing-Gung Chung
October 2011, Oncology reports,
Jehn-Hwa Kuo, and An-Cheng Huang, and Jen-Jyh Lin, and Kuang-Chi Lai, and Rick Sai-Chuen Wu, and Jiun-Long Yang, and Bin-Chuan Ji, and Mei-Due Yang, and Yung-Lin Chu, and Jing-Gung Chung
December 2001, Urological research,
Jehn-Hwa Kuo, and An-Cheng Huang, and Jen-Jyh Lin, and Kuang-Chi Lai, and Rick Sai-Chuen Wu, and Jiun-Long Yang, and Bin-Chuan Ji, and Mei-Due Yang, and Yung-Lin Chu, and Jing-Gung Chung
May 2008, Scandinavian journal of immunology,
Copied contents to your clipboard!